Clinical trial
Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and…
NCT00001575 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001575 |
|---|---|
| Title | Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin's Disease, Lymphoma, Non-Hodgkin |
| Intervention type | Biological, Drug |
| Interventions | Y-90 Humanized Anti-Tac, Calcium-DTPA |
| Enrollment | 87 |
| Start date | Apr 1, 1997 |
| Primary completion | Nov 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | Nov 4, 1999 |
| Last update posted | Dec 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: